{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:39:17Z","timestamp":1791254357812,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T00:00:00Z","timestamp":1453334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T00:00:00Z","timestamp":1453334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01CA180061-01"],"award-info":[{"award-number":["1R01CA180061-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R25T CA057730"],"award-info":[{"award-number":["R25T CA057730"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cancer Center Support Grant","award":["CA016672"],"award-info":[{"award-number":["CA016672"]}]},{"name":"The State of Texas Grant for Rare and Aggressive Breast Cancer"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s10552-015-0712-3","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T01:59:01Z","timestamp":1453341541000},"page":"359-366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Epidemiological risk factors associated with inflammatory breast cancer subtypes"],"prefix":"10.1007","volume":"27","author":[{"given":"Rachel L.","family":"Atkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randa","family":"El-Zein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Lucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese B.","family":"Bevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto T.","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A.","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abenaa M.","family":"Brewster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,21]]},"reference":[{"key":"712_CR1","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/jnci\/dji172","volume":"97","author":"KW Hance","year":"2005","unstructured":"Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH (2005) Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the national cancer institute. J Natl Cancer Inst 97:966\u2013975","journal-title":"J Natl Cancer Inst"},{"key":"712_CR2","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1200\/JCO.2004.04.068","volume":"22","author":"JA Low","year":"2004","unstructured":"Low JA, Berman AW, Steinberg SM, Danforth DN, Lippman ME, Swain SM (2004) Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. J Clin Oncol 22:4067\u20134074","journal-title":"J Clin Oncol"},{"key":"712_CR3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.clbc.2013.08.004","volume":"13","author":"A Natori","year":"2013","unstructured":"Natori A, Hayashi N, Soejima K, Deshpande GA, Takahashi O, Cristofanilli M et al (2013) A comparison of epidemiology, biology, and prognosis of inflammatory breast cancer in Japanese and US populations. Clin Breast Cancer 13:460\u2013464","journal-title":"Clin Breast Cancer"},{"key":"712_CR4","unstructured":"Tsai CJ, Li J, Gonzalez-Angulo AM, Allen PK, Woodward WA, Ueno NT et al (2013) Outcomes after multidisciplinary treatment of inflammatory breast cancer in the era of neoadjuvant HER2-directed therapy. Am J Clin Oncol"},{"key":"712_CR5","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie T, Perou R, Tibshirani R, Aas T, Geisler S, Johnsen H et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869\u201310874","journal-title":"Proc Natl Acad Sci USA"},{"key":"712_CR6","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie R, Eisen MB, Van De Rijn M, Jeffrey SS, Ress CA et al (2000) Molecular portraits of human breast tumors. Nature 406:747\u2013752","journal-title":"Nature"},{"key":"712_CR7","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1158\/1078-0432.CCR-12-2549","volume":"19","author":"SJ Van Laere","year":"2013","unstructured":"Van Laere SJ, Ueno NT, Finetti P, Vermeulen P, Lucci A, Robertson FM et al (2013) Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets. Clin Cancer Res 19:4685\u20134696","journal-title":"Clin Cancer Res"},{"key":"712_CR8","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1200\/JCO.1998.16.12.3731","volume":"16","author":"S Chang","year":"1998","unstructured":"Chang S, Buzdar AU, Hursting SD (1998) Inflammatory breast cancer and body mass index. J Clin Oncol 16:3731\u20133735","journal-title":"J Clin Oncol"},{"key":"712_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.breast.2005.08.018","volume":"15","author":"MG Le","year":"2006","unstructured":"Le MG, Arriagada R, Bahi J, Pfeiffer F, Cammoun M, Tabbane F et al (2006) Are risk factors for breast cancer similar in women with inflammatory breast cancer and in those with non-inflammatory breast cancer? Breast 15:355\u2013362","journal-title":"Breast"},{"key":"712_CR10","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1093\/jnci\/djt206","volume":"105","author":"C Schairer","year":"2013","unstructured":"Schairer C, Li Y, Frawley P, Graubard BI, Wellman RD, Buist DS et al (2013) Risk factors for inflammatory breast cancer and other invasive breast cancers. J Natl Cancer Inst 105:1373\u20131384","journal-title":"J Natl Cancer Inst"},{"key":"712_CR11","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/bcr2261","volume":"11","author":"ML Kwan","year":"2009","unstructured":"Kwan ML, Kushi LH, Weltzien E, Maring B, Kutner SE, Fulton RS et al (2009) Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res 11:R31","journal-title":"Breast Cancer Res"},{"key":"712_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10549-007-9632-6","volume":"109","author":"RC Millikan","year":"2008","unstructured":"Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG et al (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109:123\u2013139","journal-title":"Breast Cancer Res Treat"},{"key":"712_CR13","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.1002\/cncr.25443","volume":"116","author":"SS Shinde","year":"2010","unstructured":"Shinde SS, Forman MR, Kuerer HM, Yan K, Peintinger F, Hunt KK et al (2010) Higher parity and shorter breastfeeding duration: association with triple-negative phenotype of breast cancer. Cancer 116:4933\u20134943","journal-title":"Cancer"},{"key":"712_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.breast.2012.08.005","volume":"22","author":"FP Turkoz","year":"2013","unstructured":"Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F et al (2013) Association between common risk factors and molecular subtypes in breast cancer patients. Breast 22:344\u2013350","journal-title":"Breast"},{"key":"712_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1158\/1055-9965.EPI-06-0806","volume":"16","author":"XR Yang","year":"2007","unstructured":"Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B et al (2007) Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomark Prev 16:439\u2013443","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"712_CR16","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1093\/annonc\/mdv379","volume":"26","author":"F Islami","year":"2015","unstructured":"Islami F, Liu Y, Jemal A, Zhou J, Weiderpass E, Colditz G et al (2015) Breastfeeding and breast cancer risk by receptor status-a systematic review and meta-analysis. Ann Oncol 26:2398\u20132407","journal-title":"Ann Oncol"},{"issue":"6","key":"712_CR17","doi-asserted-by":"publisher","first-page":"djv048","DOI":"10.1093\/jnci\/djv048","volume":"107","author":"BA Kohler","year":"2015","unstructured":"Kohler BA, Shermann RL, Howlader N, Jemal A, Ryerson AB, Henry KA et al (2015) Annual report to the nation on the status of cancer, 1975\u20132011, featuring incidence of breast cancer subtypes by race\/ethnicity, poverty, and state. J Natl Cancer Inst 107(6):djv048","journal-title":"J Natl Cancer Inst"},{"key":"712_CR18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/annonc\/mdq345","volume":"22","author":"S Dawood","year":"2011","unstructured":"Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA et al (2011) International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol 22:515\u2013523","journal-title":"Ann Oncol"},{"key":"712_CR19","first-page":"225","volume-title":"AJCC Cancer Staging Manual","year":"2002","unstructured":"Green F, Page D, Flemming I et al (eds) (2002) AJCC Cancer Staging Manual, 6th edn. Springer, New York, pp 225\u2013281","edition":"6"},{"key":"712_CR20","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1158\/1940-6207.CAPR-11-0110","volume":"4","author":"PG Morris","year":"2011","unstructured":"Morris PG, Hudis CA, Giri D, Morrow M, Falcone DJ, Zhou XK et al (2011) Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res (Phila) 4:1021\u20131029","journal-title":"Cancer Prev Res (Phila)"},{"key":"712_CR21","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s10549-011-1789-3","volume":"131","author":"X Sun","year":"2012","unstructured":"Sun X, Casbas-Hernandez P, Bigelow C, Makowski L, Joseph Jerry D, Smith Schneider S et al (2012) Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression. Breast Cancer Res Treat 131:1003\u20131012","journal-title":"Breast Cancer Res Treat"},{"key":"712_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/jnci\/djq524","volume":"103","author":"T Iwamoto","year":"2011","unstructured":"Iwamoto T, Bianchini G, Booser D, Qi Y, Coutant C, Shiang CY et al (2011) Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer. J Natl Cancer Inst 103:264\u2013272","journal-title":"J Natl Cancer Inst"},{"key":"712_CR23","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s10549-010-1280-6","volume":"125","author":"T Iwamoto","year":"2011","unstructured":"Iwamoto T, Bianchini G, Qi Y, Cristofanilli M, Lucci A, Woodward WA et al (2011) Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer. Breast Cancer Res Treat 125:785\u2013795","journal-title":"Breast Cancer Res Treat"},{"key":"712_CR24","doi-asserted-by":"publisher","first-page":"R77","DOI":"10.1186\/bcr3471","volume":"15","author":"RL Atkinson","year":"2013","unstructured":"Atkinson RL, Yang WT, Rosen DG, Landis MD, Wong H, Lewis MT et al (2013) Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency. Breast Cancer Res 15:R77","journal-title":"Breast Cancer Res"},{"key":"712_CR25","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s10552-009-9331-1","volume":"20","author":"KF Trivers","year":"2009","unstructured":"Trivers KF, Lund MJ, Porter PL, Liff JM, Flagg WE, Coates RJ et al (2009) The epidemiology of triple negative breast cancer, including race. Cancer Causes Control 20:1071\u20131082","journal-title":"Cancer Causes Control"},{"key":"712_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-014-2852-7","volume":"144","author":"KN Anderson","year":"2014","unstructured":"Anderson KN, Schwab RB, Martinez ME (2014) Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat 144:1\u201310","journal-title":"Breast Cancer Res Treat"},{"key":"712_CR27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/cncr.27707","volume":"119","author":"AA Bailes","year":"2013","unstructured":"Bailes AA, Kuerer HM, Lari SA, Jones LA, Brewster AM (2013) Impact of race and ethnicity on features and outcome of ductal carcinoma in situ of the breast. Cancer 119:150\u2013157","journal-title":"Cancer"},{"key":"712_CR28","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1200\/JCO.2013.54.1870","volume":"32","author":"F Ades","year":"2014","unstructured":"Ades F, Zardvas D, Bozovic-Spasojevic I, Pugliano L, Fumagalli D, de Azambuja E, Viale G et al (2014) Luminal B breast cancer: molecular characterization, clinical management and future perspectives. J Clin Oncol 32:2794\u20132803","journal-title":"J Clin Oncol"},{"key":"712_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1677\/erc.0.0080191","volume":"8","author":"M Dowsett","year":"2001","unstructured":"Dowsett M (2001) Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer. Endocr Relat Cancer 8:191\u2013195","journal-title":"Endocr Relat Cancer"},{"key":"712_CR30","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s10552-011-9750-7","volume":"22","author":"GC Kabat","year":"2011","unstructured":"Kabat GC, Kim M, Phipps AI, Ci Li, Messina CR, Wactawski-Wende J et al (2011) Smoking and alcohol consumption in relation to risk of triple negative breast cancer in a cohort of postmenopausal women. Cancer Causes Control 22:775\u2013783","journal-title":"Cancer Causes Control"},{"key":"712_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ypmed.2009.08.009","volume":"49","author":"N Travier","year":"2009","unstructured":"Travier N, Agudo AM, May C, Gonzalez J, Luan H, Besson H et al (2009) Smoking and body fatness measurements: a cross-sectional analysis in the EPIC-PANACEA study. Prev Med 49:365\u2013373","journal-title":"Prev Med"},{"key":"712_CR32","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1001\/jama.2012.39","volume":"307","author":"KM Flegal","year":"2012","unstructured":"Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999\u20132010. JAMA 307:491\u2013497","journal-title":"JAMA"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-015-0712-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-015-0712-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-015-0712-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-015-0712-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T16:03:45Z","timestamp":1589645025000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-015-0712-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,21]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["712"],"URL":"https:\/\/doi.org\/10.1007\/s10552-015-0712-3","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,21]]},"assertion":[{"value":"21 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}